Pansacala, Moises L.
HRN: 28-21-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2025
MEBENDAZOLE 500MG (TAB)
12/04/2025
12/11/2025
PO
500mg
Tid
E Histolytica/ Dispar Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes